Trial Profile
A Phase 2a, Open Label, Multiple-Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of Teplizumab in Adults with Moderate or More Severe Psoriasis.
Status:
Not stated
Phase of Trial:
Phase II
Latest Information Update: 25 Jan 2010
Price :
$35
*
At a glance
- Drugs Teplizumab (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors MacroGenics
- 25 Jan 2010 New trial record